| 1 |
35083881 | LDLR dysfunction induces LDL accumulation and promotes pulmonary fibrosis. | 2022 Jan |
1 |
| 2 |
35571088 | Di'ao Xinxuekang Capsule Improves the Anti-Atherosclerotic Effect of Atorvastatin by Downregulating the SREBP2/PCSK9 Signalling Pathway. | 2022 |
1 |
| 3 |
34804419 | Modulatory role of atorvastatin against high-fat diet and zymosan-induced activation of TLR2/NF-ƙB signaling pathway in C57BL/6 mice. | 2021 Aug |
1 |
| 4 |
32466086 | Impact of the Gut Microbiota on Atorvastatin Mediated Effects on Blood Lipids. | 2020 May 25 |
1 |
| 5 |
30015940 | Short‑term use of atorvastatin affects glucose homeostasis and suppresses the expression of LDL receptors in the pancreas of mice. | 2018 Sep |
3 |
| 6 |
25997922 | Atorvastatin Attenuates Bone Loss and Aortic Valve Atheroma in LDLR Mice. | 2015 |
1 |
| 7 |
23336815 | Atorvastatin and pitavastatin reduce oxidative stress and improve IR/LDL-R signals in Alzheimer's disease. | 2013 Mar |
1 |
| 8 |
21953346 | Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice. | 2012 Mar |
2 |
| 9 |
22104174 | Activation of TGF-β receptors and Smad proteins by atorvastatin is related to reduced atherogenesis in ApoE/LDLR double knockout mice. | 2012 |
2 |
| 10 |
21371558 | Simultaneous intake of oat bran and atorvastatin reduces their efficacy to lower lipid levels and atherosclerosis in LDLr-/- mice. | 2011 Jul |
1 |
| 11 |
21440631 | Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis. | 2011 Jul |
1 |
| 12 |
19556713 | Atorvastatin Increases Endoglin, SMAD2, Phosphorylated SMAD2/3 and eNOS Expression in ApoE/LDLR Double Knockout Mice. | 2009 Jun |
1 |
| 13 |
18289605 | Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice. | 2008 Mar 26 |
2 |
| 14 |
16957178 | Plant sterol or stanol esters retard lesion formation in LDL receptor-deficient mice independent of changes in serum plant sterols. | 2006 Dec |
1 |
| 15 |
11387232 | Growth hormone reduces plasma cholesterol in LDL receptor-deficient mice. | 2001 Jun |
1 |